Target Price | HKD75.48 |
Price | HKD60.90 |
Potential |
23.94%
register free of charge
|
Number of Estimates | 24 |
24 Analysts have issued a price target Shenzhou International Group 2026 .
The average Shenzhou International Group target price is HKD75.48.
This is
23.94%
register free of charge
HKD99.75
63.79%
register free of charge
HKD50.50
17.08%
register free of charge
|
|
A rating was issued by 29 analysts: 27 Analysts recommend Shenzhou International Group to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Shenzhou International Group stock has an average upside potential 2026 of
23.94%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 31.26 | 35.59 |
14.79% | 13.85% | |
EBITDA Margin | 26.23% | 26.92% |
13.93% | 2.62% | |
Net Margin | 21.77% | 20.50% |
19.29% | 5.84% |
26 Analysts have issued a sales forecast Shenzhou International Group 2025 . The average Shenzhou International Group sales estimate is
This results in the following potential growth metrics:
26 Shenzhou International Group Analysts have issued a net profit forecast 2025. The average Shenzhou International Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 4.53 | 4.85 |
36.86% | 7.06% | |
P/E | 12.55 |
26 Analysts have issued a Shenzhou International Group forecast for earnings per share. The average Shenzhou International Group EPS is
This results in the following potential growth metrics and future valuations:
Shenzhou International Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.